Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
DOWNLOAD WHITEPAPER

Building The Industry’s Most Advanced Modeling Engine

For the past ten years, the industry has seen an increased demand to determine fair market value of CRO and other clinical trial service providers.

Not only do these costs account for the largest portion of the direct clinical trial cost at the onset of the trial, but the change orders associated with these cost categories are the main culprits for significant cost swings during the trial execution.

While total negotiated cost is of importance during planning and budgeting exercises or CRO negotiation, the estimation of actual activity- completed costs and accurate time distribution of cost throughout the lifecycle of the trial (reforecasting), are equally critical for financial planning and reporting and for overall study risk management.



Download to find out more.

Close
Close
Close

Go Top